IL139217A0 - Monoclonal antibodies to the human ldl receptor, their production and use - Google Patents

Monoclonal antibodies to the human ldl receptor, their production and use

Info

Publication number
IL139217A0
IL139217A0 IL13921700A IL13921700A IL139217A0 IL 139217 A0 IL139217 A0 IL 139217A0 IL 13921700 A IL13921700 A IL 13921700A IL 13921700 A IL13921700 A IL 13921700A IL 139217 A0 IL139217 A0 IL 139217A0
Authority
IL
Israel
Prior art keywords
production
monoclonal antibodies
ldl receptor
human ldl
human
Prior art date
Application number
IL13921700A
Other languages
English (en)
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26323933&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL139217(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from IL13502500A external-priority patent/IL135025A0/xx
Application filed by Applied Research Systems filed Critical Applied Research Systems
Priority to IL13921700A priority Critical patent/IL139217A0/xx
Priority to NZ520944A priority patent/NZ520944A/en
Priority to PT01912086T priority patent/PT1263790E/pt
Priority to AU2001241002A priority patent/AU2001241002B8/en
Priority to EEP200200517A priority patent/EE200200517A/xx
Priority to CA2402593A priority patent/CA2402593C/en
Priority to BR0109164-6A priority patent/BR0109164A/pt
Priority to ES01912086T priority patent/ES2282238T3/es
Priority to DE60128452T priority patent/DE60128452T2/de
Priority to HK03108147.2A priority patent/HK1055750B/xx
Priority to HR20020704A priority patent/HRP20020704B1/xx
Priority to JP2001567800A priority patent/JP4768193B2/ja
Priority to YUP-686/02A priority patent/RS51406B/sr
Priority to IL15171301A priority patent/IL151713A0/xx
Priority to US10/221,679 priority patent/US6849720B2/en
Priority to KR1020027011767A priority patent/KR100882081B1/ko
Priority to PL358381A priority patent/PL206041B1/pl
Priority to SI200130736T priority patent/SI1263790T1/sl
Priority to AU4100201A priority patent/AU4100201A/xx
Priority to CN018065740A priority patent/CN1418225B/zh
Priority to EP01912086A priority patent/EP1263790B1/en
Priority to SK1312-2002A priority patent/SK287348B6/sk
Priority to AT01912086T priority patent/ATE362490T1/de
Priority to DK01912086T priority patent/DK1263790T3/da
Priority to PCT/IL2001/000216 priority patent/WO2001068710A1/en
Priority to HU0300142A priority patent/HU226194B1/hu
Priority to CZ20023098A priority patent/CZ20023098A3/cs
Priority to EA200200974A priority patent/EA007494B1/ru
Priority to MXPA02009091A priority patent/MXPA02009091A/es
Priority to ARP010101148A priority patent/AR028518A1/es
Priority to UA2002108101A priority patent/UA78489C2/uk
Publication of IL139217A0 publication Critical patent/IL139217A0/xx
Priority to ZA200206654A priority patent/ZA200206654B/en
Priority to NO20024223A priority patent/NO330904B1/no
Priority to BG107063A priority patent/BG65762B1/bg
Priority to CY20071100939T priority patent/CY1108020T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL13921700A 2000-03-13 2000-10-23 Monoclonal antibodies to the human ldl receptor, their production and use IL139217A0 (en)

Priority Applications (35)

Application Number Priority Date Filing Date Title
IL13921700A IL139217A0 (en) 2000-03-13 2000-10-23 Monoclonal antibodies to the human ldl receptor, their production and use
EA200200974A EA007494B1 (ru) 2000-03-13 2001-03-08 Моноклональные антитела к растворимому рецептору лпнп человека, способы их получения и применения и гибридомы, продуцирующие указанные антитела
MXPA02009091A MXPA02009091A (es) 2000-03-13 2001-03-08 Anticuerpos monoclonales para el receptor humano para lipoproteinas de baja densidad, su produccion y uso.
KR1020027011767A KR100882081B1 (ko) 2000-03-13 2001-03-08 사람 ｌｄｌ 수용체에 대한 단클론항체, 이들의 생산 및용도
AU4100201A AU4100201A (en) 2000-03-13 2001-03-08 Monoclonal antibodies to the human ldl receptor, their production and use
AU2001241002A AU2001241002B8 (en) 2000-03-13 2001-03-08 Monoclonal antibodies to the human LDL receptor, their production and use
EEP200200517A EE200200517A (et) 2000-03-13 2001-03-08 Monoklonaalne antikeha, selle valmistamine ning kasutamine inimese madala tihedusega lipoproteiinide retseptori (LDLR) tuvastamiseks ja puhastamiseks
CA2402593A CA2402593C (en) 2000-03-13 2001-03-08 Monoclonal antibodies to the human ldl receptor, their production and use
BR0109164-6A BR0109164A (pt) 2000-03-13 2001-03-08 Anticorpos monoclonais para o receptor humano para ldl, produção e uso dos mesmos
ES01912086T ES2282238T3 (es) 2000-03-13 2001-03-08 Anticuerpos monoclonales contra el receptor ldl humano, su produccion y uso.
DE60128452T DE60128452T2 (de) 2000-03-13 2001-03-08 Monoklonale antikörper gegen den menschlichen ldl-rezeptor, deren herstellung und verwendung
HK03108147.2A HK1055750B (en) 2000-03-13 2001-03-08 Monoclonal antibodies to the human ldl receptor, their production and use
HR20020704A HRP20020704B1 (en) 2000-03-13 2001-03-08 Monoclonal antibodies to the human ldl receptor, their production and use
JP2001567800A JP4768193B2 (ja) 2000-03-13 2001-03-08 ヒトｌｄｌ受容体に対するモノクローナル抗体、その産生および用途
YUP-686/02A RS51406B (sr) 2000-03-13 2001-03-08 Monoklonska antitela na humani ldl receptor, njihova produkcija i korišćenje
IL15171301A IL151713A0 (en) 2000-03-13 2001-03-08 Monoclonal antibodies to the human ldl receptor, their production and use
US10/221,679 US6849720B2 (en) 2000-03-13 2001-03-08 Monoclonal antibodies to the human LDL receptor, their production and use
NZ520944A NZ520944A (en) 2000-03-13 2001-03-08 Monoclonal antibodies to the human LDL receptor, their production and use
PL358381A PL206041B1 (pl) 2000-03-13 2001-03-08 Przeciwciało monoklonalne, przeciwciało chimerowe, całkowicie humanizowane przeciwciało, przeciwciało anty-anty-ID albo jego fragment oraz ich zastosowanie, klony hybrydoma, sposób wykrywania i/albo analizy ilościowej ludzkiego LDLR, sposób oczyszczania oraz sposób hamowania in vitro replikacji wirusa zapalenia wątroby typu C
SI200130736T SI1263790T1 (sl) 2000-03-13 2001-03-08 Monoklonska protitelesa za humani receptor ldl, njihova priprava in uporaba
PT01912086T PT1263790E (pt) 2000-03-13 2001-03-08 Anticorpos monoclonais para com o receptor ldl humano, a sua produção e a sua utilização.
CN018065740A CN1418225B (zh) 2000-03-13 2001-03-08 人低密度脂蛋白受体的单克隆抗体及其制备和用途
EP01912086A EP1263790B1 (en) 2000-03-13 2001-03-08 Monoclonal antibodies to the human ldl receptor, their production and use
SK1312-2002A SK287348B6 (sk) 2000-03-13 2001-03-08 Monoklonálne protilátky proti ľudskému LDL receptoru, spôsob ich prípravy a ich použitie
AT01912086T ATE362490T1 (de) 2000-03-13 2001-03-08 Monoklonale antikörper gegen den menschlichen ldl-rezeptor, deren herstellung und verwendung
DK01912086T DK1263790T3 (da) 2000-03-13 2001-03-08 Monoklonale antistoffer for den humane LDL-receptor, deres produktionsmetode og anvendelse
PCT/IL2001/000216 WO2001068710A1 (en) 2000-03-13 2001-03-08 Monoclonal antibodies to the human ldl receptor, their production and use
HU0300142A HU226194B1 (hu) 2000-03-13 2001-03-08 Humán szolubilis LDL-receptorra specifikus monoklonális ellenanyagok, elõállításuk és alkalmazásuk
CZ20023098A CZ20023098A3 (cs) 2000-03-13 2001-03-08 Monoklonální protilátky proti receptoru lidského LDL, jejich produkce a použití
ARP010101148A AR028518A1 (es) 2000-03-13 2001-03-12 Anticuerpos monoclonales, anticuerpos quimericos, anticuerpos totalmente humanizados y anticuerpos anti-anti-id o fragmentados de los mismos; metodo para prepararlos, metodo para purificar ldlr humano, utilizando dichos anticuerpos
UA2002108101A UA78489C2 (en) 2000-03-13 2001-08-03 Monoclonal antibody, chimeric antibody, completely humanized antibody, antibody to antiidiotypic antibody or fragment thereof to receptor of lipoproteins of low density (lpld) of human, a method for obtaining and use thereof
ZA200206654A ZA200206654B (en) 2000-03-13 2002-08-20 Monoclonal antibodies to the human LDL receptor, their production and use.
NO20024223A NO330904B1 (no) 2000-03-13 2002-09-04 Monoklonalt antistoff, kimerisk antistoff, fullt humanisert antistoff, anti-anti-ID-antistoff eller fragment derav som binder human loselig LDL-reseptor, anvendelse av samme som medikament og fremstilling og av et medikament til behandling av hepatitt-C-infeksjon, hybridomkloner, fremgangsmate pavisning og/eller kvantifisering av human loselig LDLR, for fremstilling av et monoklonalt antistoff, for rensing av human LDLR, og in vitro-fremgangsmate for inhibering av replikasjon av hepatitt-C-virus.
BG107063A BG65762B1 (bg) 2000-03-13 2002-09-05 Моноклонални антитела за човешки ldl рецептор, тяхното получаване и използване
CY20071100939T CY1108020T1 (el) 2000-03-13 2007-07-13 Μονοκλωνικα αντισωματα στον ανθρωπινο υποδοχεα ldl, η παραγωγη και χρηση τους

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL13502500A IL135025A0 (en) 2000-03-13 2000-03-13 Monoclonal antibodies to the human ldl receptor, their production and use
IL13921700A IL139217A0 (en) 2000-03-13 2000-10-23 Monoclonal antibodies to the human ldl receptor, their production and use

Publications (1)

Publication Number Publication Date
IL139217A0 true IL139217A0 (en) 2001-11-25

Family

ID=26323933

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13921700A IL139217A0 (en) 2000-03-13 2000-10-23 Monoclonal antibodies to the human ldl receptor, their production and use
IL15171301A IL151713A0 (en) 2000-03-13 2001-03-08 Monoclonal antibodies to the human ldl receptor, their production and use

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL15171301A IL151713A0 (en) 2000-03-13 2001-03-08 Monoclonal antibodies to the human ldl receptor, their production and use

Country Status (32)

Country Link
US (1) US6849720B2 (sr)
EP (1) EP1263790B1 (sr)
JP (1) JP4768193B2 (sr)
KR (1) KR100882081B1 (sr)
CN (1) CN1418225B (sr)
AR (1) AR028518A1 (sr)
AT (1) ATE362490T1 (sr)
AU (2) AU2001241002B8 (sr)
BG (1) BG65762B1 (sr)
BR (1) BR0109164A (sr)
CA (1) CA2402593C (sr)
CY (1) CY1108020T1 (sr)
CZ (1) CZ20023098A3 (sr)
DE (1) DE60128452T2 (sr)
DK (1) DK1263790T3 (sr)
EA (1) EA007494B1 (sr)
EE (1) EE200200517A (sr)
ES (1) ES2282238T3 (sr)
HR (1) HRP20020704B1 (sr)
HU (1) HU226194B1 (sr)
IL (2) IL139217A0 (sr)
MX (1) MXPA02009091A (sr)
NO (1) NO330904B1 (sr)
NZ (1) NZ520944A (sr)
PL (1) PL206041B1 (sr)
PT (1) PT1263790E (sr)
RS (1) RS51406B (sr)
SI (1) SI1263790T1 (sr)
SK (1) SK287348B6 (sr)
UA (1) UA78489C2 (sr)
WO (1) WO2001068710A1 (sr)
ZA (1) ZA200206654B (sr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0114629D0 (en) * 2001-06-15 2001-08-08 Pfizer Ltd Method
JP5133561B2 (ja) 2003-06-19 2013-01-30 メルク セローノ ソシエテ アノニム プリオン変換を調節する因子の使用
FR2889533B1 (fr) * 2005-08-03 2007-10-12 Lab Francais Du Fractionnement Anticorps diriges contre le recepteur du ldl
FR2889532B1 (fr) * 2005-08-03 2007-10-12 Lab Francais Du Fractionnement Anticorps diriges contre le recepteur du ldl
JP2009526991A (ja) * 2006-02-17 2009-07-23 パオロ・ラ・コッラ 増殖性疾患及び／又はコンホメーション病の診断方法
FR2910896B1 (fr) * 2006-12-29 2012-11-16 Lab Francais Du Fractionnement Anticorps monoclonal dirige contre le recepteur humain des ldl
IL182956A0 (en) 2007-05-03 2008-01-20 Yeda Res & Dev Glycan modified soluble receptors and binding proteins and their use
IL188628A0 (en) * 2008-01-07 2008-12-29 Yeda Res & Dev Use of soluble ldl-r for viral hepatitis
GB0922377D0 (en) * 2009-12-22 2010-02-03 Arab Gulf University The Mutant LDL receptor
US20130129676A1 (en) 2010-05-25 2013-05-23 Universite De Strasbourg Combination of anti-envelope antibodies and anti-receptor antibodies for the treatment and prevention of hcv infection
WO2013024155A1 (en) 2011-08-17 2013-02-21 Inserm (Institut National De La Sante Et De La Recherche Medicale) Combinations of anti-hcv-entry factor antibodies and direct acting antivirals for the treatment and the prevention of hcv infection
WO2013024156A2 (en) 2011-08-17 2013-02-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Combinations of anti-hcv-entry factor antibodies and interferons for the treatment and the prevention of hcv infection
WO2013024157A2 (en) 2011-08-17 2013-02-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Combinations of host targeting agents for the treatment and the prevention of hcv infection
CN103111270B (zh) * 2013-02-26 2015-06-10 王业富 一种乙型肝炎抗原蛋白的吸附材料及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5182364A (en) * 1990-02-26 1993-01-26 The Scripps Research Institute Polypeptide analogs of apolipoprotein E
US5496926A (en) * 1992-01-19 1996-03-05 Yeda Research And Development Co. Ltd. Process of preparing a soluble LDL receptor
US5945308A (en) * 1998-04-03 1999-08-31 Incyte Pharmaceuticals, Inc. Human oxidized LDL receptor
JP2000279174A (ja) * 1999-03-30 2000-10-10 Bml Inc ヒトｌｄｌレセプターに対するモノクローナル抗体及びこれを用いる家族性高脂血症の判定方法

Also Published As

Publication number Publication date
NO330904B1 (no) 2011-08-15
HUP0300142A3 (en) 2005-07-28
EP1263790A1 (en) 2002-12-11
NO20024223D0 (no) 2002-09-04
NZ520944A (en) 2004-04-30
KR100882081B1 (ko) 2009-02-10
HK1055750A1 (en) 2004-01-21
YU68602A (sh) 2006-03-03
CA2402593C (en) 2012-07-03
CN1418225B (zh) 2012-04-18
NO20024223L (no) 2002-10-24
ATE362490T1 (de) 2007-06-15
MXPA02009091A (es) 2005-06-20
RS51406B (sr) 2011-02-28
AU4100201A (en) 2001-09-24
PT1263790E (pt) 2007-06-01
EP1263790B1 (en) 2007-05-16
EE200200517A (et) 2004-02-16
IL151713A0 (en) 2003-04-10
US20030186343A1 (en) 2003-10-02
CN1418225A (zh) 2003-05-14
BG107063A (bg) 2003-05-30
US6849720B2 (en) 2005-02-01
BR0109164A (pt) 2002-11-26
AU2001241002B8 (en) 2006-05-04
JP4768193B2 (ja) 2011-09-07
SK13122002A3 (sk) 2003-04-01
CY1108020T1 (el) 2013-09-04
SK287348B6 (sk) 2010-08-09
WO2001068710A1 (en) 2001-09-20
AU2001241002B2 (en) 2006-04-06
HU226194B1 (hu) 2008-06-30
KR20020089384A (ko) 2002-11-29
UA78489C2 (en) 2007-04-10
EA007494B1 (ru) 2006-10-27
JP2004506603A (ja) 2004-03-04
EA200200974A1 (ru) 2003-02-27
HUP0300142A2 (hu) 2003-06-28
PL358381A1 (en) 2004-08-09
AR028518A1 (es) 2003-05-14
BG65762B1 (bg) 2009-10-30
DE60128452T2 (de) 2007-09-13
DE60128452D1 (de) 2007-06-28
DK1263790T3 (da) 2007-07-02
HRP20020704B1 (en) 2011-01-31
ZA200206654B (en) 2003-10-20
CZ20023098A3 (cs) 2003-02-12
PL206041B1 (pl) 2010-06-30
HRP20020704A2 (en) 2004-12-31
SI1263790T1 (sl) 2007-10-31
ES2282238T3 (es) 2007-10-16
CA2402593A1 (en) 2001-09-20

Similar Documents

Publication Publication Date Title
MXPA03001590A (es) Anticuerpos para la il-1beta humana.
TWI367102B (en) Therapeutic human anti-il-1r1 monoclonal antibody
ZA200206266B (en) Antibodies that bind human interleukin-18 and methods of making and using.
MXPA03009390A (es) Anticuerpos para integrina vla-1.
IL166244A0 (en) Super humanized antibodies
IL153721A0 (en) Antibodies to human mcp-1
AU4835001A (en) Antibodies to human cd154
GB0029360D0 (en) Humanised antibodies and uses thereof
AU2608602A (en) Silensed anti-cd28 antibodies and use thereof
AU2001256325A1 (en) Human and humanized fap-alpha-specific antibodies
AU7676300A (en) Human anti-adipocyte monoclonal antibodies and their use
EP1418234A4 (en) HUMAN MONOCLONAL ANTIBODIES DIRECTED AGAINST OXIDIZED LDL RECEPTORS AND THEIR MEDICAL USE
IL151713A0 (en) Monoclonal antibodies to the human ldl receptor, their production and use
AU5441000A (en) Human monoclonal antibody
AU2002325164A1 (en) Receptor, the use thereof, and mouse antibodies
IL135025A0 (en) Monoclonal antibodies to the human ldl receptor, their production and use
EP1278538A4 (en) ANTIBODIES BINDING TO CD18 AND INHIBITING STENOSE-RELATED DISORDERS
AU2001281099A1 (en) Production of human monoclonal antibodies
GB0017139D0 (en) Human monoclonal antibodies
GB0016824D0 (en) Human monoclonal antibodies
AR028262A1 (es) Anticuerpos especificos de fap-alfa humanos
ZA200200730B (en) Human monoclonal antibodies to prostate specific membrane antigen.
GB0003359D0 (en) Monoclonal antibodies
GB0008160D0 (en) Monoclonal antibodies
GB0325391D0 (en) Human monoclonal antibodies